FDA Orange Book
Generic for Zipsor
Zipsor contains diclofenac. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Zipsor is diclofenac. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Zipsor and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Zipsor products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, oral | 25MG | Marketed (Rx) | AB | 3 | AB |
NDA 022202, held by COSETTE PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic diclofenac
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| BIONPHARMA INC | 204648 | AB (A-rated, therapeutically equivalent) | February 23, 2016 | 25MG |
| ONESOURCE SOFTGELS PTE LTD | 210078 | AB (A-rated, therapeutically equivalent) | December 3, 2019 | 25MG |
| AUROBINDO PHARMA LTD | 213875 | AB (A-rated, therapeutically equivalent) | October 19, 2021 | 25MG |
Zipsor patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 7884095 | February 24, 2029 | Method of use | U-1111 | 022202 |
| 8110606 | February 24, 2029 | Method of use | U-980 | 022202 |
| 7662858 | February 24, 2029 | Method of use | U-1035 | 022202 |
| 7939518 | February 24, 2029 | Method of use | U-980 | 022202 |
| 8623920 | February 24, 2029 | Method of use | U-1482 | 022202 |
| 9561200 | February 24, 2029 | Method of use | U-1482 | 022202 |
Zipsor NDC codes
Questions
Is there a generic for Zipsor?
Yes. The generic name for Zipsor is diclofenac. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Zipsor?
The active ingredient in Zipsor is diclofenac, per the FDA Orange Book.
When does the Zipsor patent expire?
The last patent listed for Zipsor in the Orange Book expires February 24, 2029. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Zipsor and Diclofenac
- What is Diclofenac used for?FDA label uses
- Is Diclofenac a controlled substance?Federal schedule
- Generic for CambiaFDA Orange Book
- Generic for SolarazeFDA Orange Book
- Generic for VoltarenFDA Orange Book
- Generic for ZueinoFDA Orange Book
- Generic for PennsaidFDA Orange Book
- Generic for Voltaren-xrFDA Orange Book
- Generic for CataflamFDA Orange Book
- Nonsteroidal Anti-inflammatory Drugs listFDA drug class
- Zipsor Medicare Part D coverageBy plan and state
- NDC 13913-008Zipsor NDC record
- NDC 82497-008Zipsor NDC record